This technology, FixR, is a modified peptide and delivery system aimed at reducing pathogenic late sodium currents, which are implicated in cardiac and neurological diseases, including cardiac arrhythmia.

A “late” or “persistent” sodium current disrupts sodium channel inactivation in the heart and results in cardiac arrhythmias and sudden cardiac death.

Applications: Therapeutic for cardiac arrhythmias, heart failure, and long QT syndrome 3.